Comparative skeletal muscle histopathologic and ultrastructural features in two forms of polysaccharide storage myopathy in horses.
Abstract: Polysaccharide storage myopathy (PSSM) has been found in more than 35 different horse breeds through identification of abnormal storage of polysaccharide in muscle biopsies. A dominant mutation in the glycogen synthase 1 gene (GYS1) accounts for a substantial proportion of PSSM cases in at least 17 breeds, including Quarter Horses, but some horses diagnosed with PSSM by muscle histopathologic analysis are negative for the mutation. We hypothesized that a second distinct form of glycogen storage disease exists in GYS1-negative horses with PSSM. The objectives of this study were to compare the histopathologic features, ultrastructure of polysaccharide, signalment, history, and presenting complaints of GYS1-negative Quarter Horses and related breeds with PSSM to those of GYS1-positive horses with PSSM. The total histopathologic score in frozen sections of skeletal muscle stained with hematoxylin and eosin, periodic acid Schiff (PAS) and amylase-PAS stains from 53 GYS1-negative horses did not differ from that of 52 GYS1-positive horses. Abnormal polysaccharide was fine granular or homogenous in appearance (49/53; 92%), often amylase-sensitive (28/53; 53%), more commonly located under the sarcolemma, and consisting of beta glycogen particles in GYS1-negative horses. However, in GYS1-positive horses, abnormal polysaccharide was usually coarse granular (50/52; 96%), amylase-resistant (51/52; 98%), more commonly cytoplasmic, and consisting of beta glycogen particles or, in some myofibers, filamentous material surrounded by beta glycogen particles. Retrospective analysis found that GYS1-negative horses (n = 43) were younger at presentation (4.9 +/- 0.6 years vs. 6.7 +/- 0.3 years for GYS1-positive horses) and were more likely to be intact males than GYS1-positive horses (n = 160). We concluded that 2 forms of PSSM exist and often have distinctive abnormal polysaccharide. However, because evaluation of the histologic appearance of polysaccharide can be subjective and affected by age, the gold standard for diagnosis of PSSM at present would appear to be testing for the GYS1 mutation followed by evaluating muscle biopsy for characteristic abnormal polysaccharide in those horses that are negative for the mutation.
Publication Date: 2009-07-15 PubMed ID: 19605906DOI: 10.1354/vp.08-VP-0177-M-FLGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
- Research Support
- Non-U.S. Gov't
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This research article examines Polysaccharide storage myopathy (PSSM) in horses, a condition caused by abnormal storage of polysaccharides in muscles. It suggests that there might be two distinct forms of the disorder, related to a mutation in the glycogen synthase 1 gene (GYS1).
Research Overview and Goals
- The researchers hypothesize that a second distinct form of glycogen storage disease, or PSSM, exists in GYS1-negative horses.
- By comparing the GYS1-negative Quarter Horses and related breeds with PSSM to those of GYS1-positive horses with PSSM, they aim to establish distinguishing features derived from histopathological, ultrastructural, signalment, history, and the initial complaints presented.
Methodology
- Analysis of skeletal muscle tissue from 53 GYS1-negative horses and 52 GYS1-positive horses was carried out. These tissues were stained using hematoxylin and eosin, periodic acid Schiff (PAS), and amylase-PAS stain techniques.
- Specific characteristics of abnormal polysaccharides in the muscle tissues were observed and documented. These characteristics included their appearance, sensitivity to amylase (an enzyme that breaks down polysaccharides), their location within muscle cells, and their basic structure.
- Finally, the characteristics of GYS1-negative horses were compared to those of GYS1-positive horses.
Findings
- The total histopathology score in both GYS1-negative and GYS1-positive horses showed no significant difference.
- However, distinct differences were noted in the structure and location of abnormal polysaccharides. GYS1-negative horses had finer granular or homogeneous polysaccharides, more frequently located under the sarcolemma (the cell membrane of a muscle cell).
- In contrast, GYS1-positive horses usually had coarser granular polysaccharides, which were mainly located within the cytoplasm of the cells.
- The researchers also discovered that GYS1-negative horses tended to be younger and more likely to be intact males when compared to GYS1-positive horses.
Conclusion
- Based on the observed differences in polysaccharide characteristics, the researchers concluded that there likely are two distinct forms of PSSM in horses.
- However, given variations in polysaccharide appearance due to subjective evaluation and age, the researchers suggest that the most reliable method for diagnosing PSSM would be testing for the GYS1 mutation, followed by a muscle biopsy to evaluate the presence of abnormal polysaccharides in GYS1-negative horses.
</ul
Cite This Article
APA
McCue ME, Armién AG, Lucio M, Mickelson JR, Valberg SJ.
(2009).
Comparative skeletal muscle histopathologic and ultrastructural features in two forms of polysaccharide storage myopathy in horses.
Vet Pathol, 46(6), 1281-1291.
https://doi.org/10.1354/vp.08-VP-0177-M-FL Publication
Researcher Affiliations
- Department of Veterinary Population Medicine, University of Minnesota College of Veterinary Medicine, USA. mccų@umn.edu
MeSH Terms
- Animals
- Female
- Genetic Predisposition to Disease
- Glycogen Storage Disease / genetics
- Glycogen Storage Disease / pathology
- Glycogen Storage Disease / veterinary
- Glycogen Synthase / genetics
- Glycogen Synthase / metabolism
- Horse Diseases / genetics
- Horse Diseases / pathology
- Horses
- Male
- Muscle, Skeletal / pathology
- Muscle, Skeletal / ultrastructure
- Retrospective Studies
Citations
This article has been cited 10 times.- Valberg SJ, Henry ML, Herrick KL, Velez-Irizarry D, Finno CJ, Petersen JL. Absence of myofibrillar myopathy in Quarter Horses with a histopathological diagnosis of type 2 polysaccharide storage myopathy and lack of association with commercial genetic tests.. Equine Vet J 2023 Mar;55(2):230-238.
- Zsoldos RR, Khayatzadeh N, Soelkner J, Schroeder U, Hahn C, Licka TF. Comparison of gluteus medius muscle activity in Haflinger and Noriker horses with polysaccharide storage myopathy.. J Anim Physiol Anim Nutr (Berl) 2021 May;105(3):549-557.
- Valberg SJ, Finno CJ, Henry ML, Schott M, Velez-Irizarry D, Peng S, McKenzie EC, Petersen JL. Commercial genetic testing for type 2 polysaccharide storage myopathy and myofibrillar myopathy does not correspond to a histopathological diagnosis.. Equine Vet J 2021 Jul;53(4):690-700.
- Tosi I, Art T, Cassart D, Farnir F, Ceusters J, Serteyn D, Lemieux H, Votion DM. Altered mitochondrial oxidative phosphorylation capacity in horses suffering from polysaccharide storage myopathy.. J Bioenerg Biomembr 2018 Oct;50(5):379-390.
- Valberg SJ, Nicholson AM, Lewis SS, Reardon RA, Finno CJ. Clinical and histopathological features of myofibrillar myopathy in Warmblood horses.. Equine Vet J 2017 Nov;49(6):739-745.
- Durward-Akhurst SA, Finno CJ, Barnes N, Shivers J, Guo LT, Shelton GD, Valberg SJ. Major Histocompatibility Complex I and II Expression and Lymphocytic Subtypes in Muscle of Horses with Immune-Mediated Myositis.. J Vet Intern Med 2016 Jul;30(4):1313-21.
- Polak GL, Pasqualino A, Docherty JE, Beck SJ, DiAngelo JR. The Regulation of Muscle Structure and Metabolism by Mio/dChREBP in Drosophila.. PLoS One 2015;10(8):e0136504.
- Valberg SJ, McKenzie EC, Eyrich LV, Shivers J, Barnes NE, Finno CJ. Suspected myofibrillar myopathy in Arabian horses with a history of exertional rhabdomyolysis.. Equine Vet J 2016 Sep;48(5):548-56.
- Naylor RJ, Livesey L, Schumacher J, Henke N, Massey C, Brock KV, Fernandez-Fuente M, Piercy RJ. Allele copy number and underlying pathology are associated with subclinical severity in equine type 1 polysaccharide storage myopathy (PSSM1).. PLoS One 2012;7(7):e42317.
- Isgren CM, Upjohn MM, Fernandez-Fuente M, Massey C, Pollott G, Verheyen KL, Piercy RJ. Epidemiology of exertional rhabdomyolysis susceptibility in standardbred horses reveals associated risk factors and underlying enhanced performance.. PLoS One 2010 Jul 14;5(7):e11594.
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists